WVU Rockefeller Neuroscience Institute are in next phases of their groundbreaking aneurysm device trial. The Seal-It trials ...

Here’s how it works. Still, we've got plenty of rumors from the past few months to work with, and below, you’ll find everything we’ve heard about the Samsung Galaxy S25 Edge so far.

Both of these devices are fueled by the same processor, the Snapdragon 8 Elite for Galaxy. That is essentially a slightly overclocked variant of the regular Snapdragon 8 Elite from Qualcomm.

The Galaxy S25 Ultra features a 6.9-inch WQHD+ (3120 x 1440) Dynamic AMOLED 2X display with Gorilla Armor 2 protection. That panel is flat, and it supports an adaptive refresh rate (1-120Hz).

Pliant Therapeutics shares fell sharply in pre-market trading Monday after it said it would pause its pulmonary fibrosis drug following a review by independent monitors. Shares traded 55% lower ahead ...

Patrick Holland has been a phone reviewer for CNET since 2016. He is a former theater director who occasionally makes short films. Patrick has an eye for photography and a passion for everything ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Palvella Therapeutics (PVLA) announced that it will expand SELVA, the Company’s Phase 3 clinical trial of QTORIN 3.9% rapamycin anhydrous gel for the treatment of microcystic lymphatic ...

Pliant Therapeutics shares were up 23% to $3.34 after the company said an independent Data Safety Monitoring Board is allowing it to begin the assembly of an outside expert panel to review unblinded ...

The U.S. Food and Drug Administration has cleared United Therapeutics (Nasdaq: UTHR) to begin a clinical trial that involves transplanting kidneys of gene-edited pigs into people with kidney failure.

Grace Therapeutics (GRCE) announced that its Phase 3 STRIVE-ON safety trial met its primary endpoint and provides evidence of clinical benefit when compared to orally administered nimodipine.

A clinical study testing a Pliant Therapeutics drug once considered ... next steps for the drug and the patients in the clinical trial. The pause on the Phase 2b test is voluntary, Pliant said ...